Free Trial

Surmodics (SRDX) Earnings Date, Estimates & Call Transcripts

Surmodics logo
$27.40 +0.03 (+0.11%)
As of 02:44 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Surmodics Earnings Summary

Upcoming Q3
Earnings Date
May. 7Estimated
Consensus EPS
(Apr. 30)
-$0.06
Actual EPS
(Apr. 30)
-$0.13 Missed By -$0.07
Actual Revenue
(Apr. 30)
$28.09M

Surmodics released Q2 2025 earnings on April 30, 2025, reporting an EPS of -$0.13, which missed the consensus estimate of -$0.06 by $0.07. Quarterly revenue was reported to be $28.09 million, below analysts' expectations of $32.23 million. With a trailing EPS of -$1.39, Surmodics' earnings are expected to grow 300.00% next year, from $0.20 to $0.80 per share.

Q2 2025 Earnings Resources

SRDX Upcoming Earnings

Surmodics' next earnings date is estimated for Wednesday, May 7, 2025, based on past reporting schedules.

Get Surmodics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surmodics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SRDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SRDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Surmodics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20252-$0.11-$0.09-$0.10
Q2 20252-$0.04$0.00-$0.02
Q3 20252-$0.21$0.00-$0.11
Q4 20252-$0.18$0.08-$0.05
FY 2025 8 -$0.54 -$0.01 -$0.28
Q1 20262-$0.18$0.05-$0.07
Q2 20262$0.01$0.04$0.03
Q3 20262$0.01$0.09$0.05
Q4 20262$0.04$0.07$0.06
FY 2026 8 -$0.12 $0.25 $0.07
Q1 20271$0.10$0.10$0.10
Q2 20271$0.11$0.11$0.11

Surmodics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2025
(Estimated)
--------
4/30/2025Q2 2025-$0.06-$0.13 -$0.07-$0.36$32.23M$28.09M
2/6/2025Q1 2025-$0.08-$0.04+$0.04-$0.26$33.37M-
11/6/2024--$0.27-$0.13+$0.14-$0.02$30.69M$33.23M
7/31/2024Q3 2024-$0.31-$0.27+$0.04-$0.01$30.32M$30.34M
5/1/2024Q2 2024-$0.36$0.07+$0.43$0.12$28.79M$31.96M
11/8/2023Q4 2023$0.16$0.53+$0.37$0.59$26.00M$27.97M
8/2/2023Q3 2023-$0.46$0.52+$0.98$0.52$26.70M$52.48M

Surmodics Earnings - Frequently Asked Questions

Surmodics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based off last year's report dates. Learn more on SRDX's earnings history.

Surmodics updated its FY 2025 earnings guidance on Wednesday, April, 30th. The company provided EPS guidance of -0.620--0.420 for the period, compared to the consensus earnings per share estimate of -0.260. The company issued revenue guidance of $114.0 million-$117.0 million, compared to the consensus revenue estimate of $127.3 million.

In the previous quarter, Surmodics (NASDAQ:SRDX) missed the analysts' consensus estimate of ($0.06) by $0.07 with a reported earnings per share (EPS) of ($0.13). Learn more on analysts' earnings estimate vs. SRDX's actual earnings.

Surmodics (NASDAQ:SRDX) has a recorded annual revenue of $121.58 million.

Surmodics (NASDAQ:SRDX) has a recorded net income of -$11.54 million. SRDX has generated -$1.39 earnings per share over the last four quarters.

Surmodics's earnings are expected to grow from $0.20 per share to $0.80 per share in the next year, which is a 300.00% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:SRDX) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners